Alegent Creighton Health
Omaha, NE
High Approval Rate
8+ Years Sponsoring
Alegent Creighton Health has sponsored 18 H1B visas since FY2013. The median H1B salary is $65,395.
H1B Visa Sponsorship Data • Updated with FY2024 data
Key Statistics
H1B Salary Analysis at Alegent Creighton Health
Salary Range (FY2024)
Range shows where 80% of salaries fall. The marker indicates the median.
Based on 1 H1B filings.
Salary Frequency
Hover over bars to see exact counts. Salary ranges in $25K increments.
Historical H1B Trends
Filings Over Time
Median Salary Trend
Approval Rate History
Certified: 1
Denied: 0
Where & What Alegent Creighton Health Hires For
Alegent Creighton Health sponsors H1B workers at locations including Omaha, NE for roles such as Medical and Clinical Laboratory Technologists.
Top H1B Work Locations (FY2024)
Top H1B Job Categories (FY2024)
Recent H1B Filings
View all 18 filings →Medical Lab Scientist
Omaha, NE • FY2024
$65,395
Certified
Medical Technologist
Papillion, NE • FY2023
$62,878
Certified
Medical Technologist
Papillion, NE • FY2023
$63,045
Certified
Medical Technologist
Papillion, NE • FY2023
$56,472
Certified
Medical Technologist
Omaha, NE • FY2023
$56,472
Certified
Year-by-Year Breakdown
Related H1B Sponsors
Other Healthcare Companies
Frequently Asked Questions
- Does Alegent Creighton Health sponsor H1B visas?
- Yes, Alegent Creighton Health sponsors H1B visas. They have filed 18 H1B petitions since FY2013. In FY2024, they filed 1 H1B applications.
- What is the H1B salary at Alegent Creighton Health?
- The median H1B salary at Alegent Creighton Health is $65,395 as of FY2024. Salaries range from $65,395 (10th percentile) to $65,395 (90th percentile).
- What is Alegent Creighton Health's H1B approval rate?
- Alegent Creighton Health has a 100.0% H1B approval rate in FY2024, based on 1 filed petitions.
- How many H1B visas does Alegent Creighton Health sponsor per year?
- Alegent Creighton Health sponsors an average of 2 H1B visas per year. They have been sponsoring H1B workers for 8 years (FY2013-FY2024).